EFFECT OF INTRAOPERATIVE MITOMYCIN-C APPLICATION IN OUTCOME OF EXTERNAL DACRYOCYSTORHINOSTOMY
AbstractBackground: Patients develop postoperative fibrosis at the site of operation after dacryocystorhinostomy (DCR) which results in impairment of the osteum patency. This quasi-experimental study was undertaken to determine the role of intraoperative Mitomycin C (MMC) application in maintaining postoperative patency of the osteum. Methodology: The present study was conducted at the Eye department of Ayub Medical College, Abbottabad on patients in whom routine DCR was indicated. Subjects were divided into mitomycin C (Test) and non mitomycin C (Control) groups. In test group, Mitomycin C was applied to the anastomosed flaps and osteotomy site for 30 minutes. Postoperative patients were followed for up to 6 months and outcome of patency was documented. Results: A total of 73 patients were included, divided into test (30) and control (43) groups. An overall success rate of 86.3% was obtained for patent ostia; this was based on 96.67% success in test group compared to 79.1% in the control group (p=0.031). Conclusion: Intraoperative application of Mitomycin-C significantly improves the success rate in external dacryocystorhinostomy.
Dacryocystitis. (Webpage). Wikipedia the Free Encyclopedia. Accessed May 21, 2015. Available from: URL: https://en.wikipedia.org/wiki/Dacryocystitis.
Pearson Andrew. Lacrimal drainage system (Chapter No. 5). In: Kanski J J. Clinical Ophthalmology. 6th ed. London: Butterworth-Heinemann, 2007:151–64.
Oill PA, Montgomerie JZ, Cryan WS, Edwards JE. Specialty conference. Infectious disease emergencies. Part V: patients presenting with localized infections. West J Med 1977;126(3):196–208.
American Academy of Ophthalmology. Abnormalities of the Lacrimal Secretory and Drainage Systems. In: Orbit, Eyelids, and Lacrimal System. Basic and Clinical Science Course. San Francisco: American Academy of Ophthalmology, 2002:265–300.
Adenis JP, Sommer U, Robert PY. Use of mitomycin C (MMC) for dacryocystorhinostomy interventions. J Fr Ophtalmol 2005;28(4):443–6.
Yildirim C, Yaylali V, Esme A, Ozden S. Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy. Int Ophthalmol 2007;27(1):31–5.
Yalaz M, Firinciogullari E, Zeren H. Use of mitomycin C and 5-fluorouracil in external dacryocystorhinostomy. Orbit 1999;18(4):239–45.
Rahman A, Channa S, Niazi JH, Memon MS. Dacryocystorhinostomy without intubation with intraoperative mitomycin-C. J Coll Physicians Surg Pak 2006;16(7):476–8.
You YA, Fang CT. Intraoperative mitomycin C in dacryocystorhinostomy. Ophthal Plast Reconstr Surg 2001;17(2):115–9.
Gonzalvo Ibáñez FJ, Fuertes Fernández I, Fernández Tirado FJ, Hernández Delgado G, Rabinal Arbués F, Honrubia López FM. External dacryocystorhinostomy with mitomycin C. Clinical and anatomical evaluation with helical computed tomography. Arch Soc Esp Oftalmol 2000;75(9):611–7.
Cheng SM, Feng YF, Xu L, Li Y, Huang JH. Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis. PLoS One 2013;8(5):e62737.
Liao SL, Kao SC, Tseng JH, Chen MS, Hou PK. Results of intraoperative Mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol 2000;84(8):903–6.
Zilelioğlu G, Uğurbaş SH, Anadolu Y, Akiner M, Aktürk T. Adjunctive use of Mitomycin C on endoscopic lacrimal surgery. Br J Ophthalmol 1998;82(1):63–6.
Ghosh S, Roychoudhury A, Roychoudhury BK. Use of Mitomycin C in Endo-DCR. Indian J Otolarngol Head Neck Surg 2006;58(4):368–9.